RegeneRx Biopharmaceuticals Inc. (OTCMKTS:RGRX – Get Free Report)’s share price crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.10 and traded as low as $0.0002. RegeneRx Biopharmaceuticals shares last traded at $0.0002, with a volume of 169 shares changing hands.
RegeneRx Biopharmaceuticals Stock Performance
The stock’s 50 day moving average price is $0.10 and its two-hundred day moving average price is $0.04.
About RegeneRx Biopharmaceuticals
RegeneRx Biopharmaceuticals, Inc, a biopharmaceutical company, focuses on the development of therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair, and regeneration. The company is developing RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease, or other pathology; RGN-352, an injectable formulation for the treatment of cardiovascular diseases, central and peripheral nervous system diseases, and other medical indications; and RGN-137, a topical gel for the treatment of dermal wounds and reduction of scar tissue.
Read More
- Five stocks we like better than RegeneRx Biopharmaceuticals
- 3 Warren Buffett Stocks to Buy Now
- 3 Big Earnings Misses: Is It Time to Buy the Dip?
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Is Robinhood’s 11% Post-Earnings Fall a Buy-the-Dip Opportunity?
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- AI Demand Is Coming—Is Microchip Technology Ready?
Receive News & Ratings for RegeneRx Biopharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RegeneRx Biopharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
